Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Aroa Biosurgery Ltd banner

Aroa Biosurgery Ltd
ASX:ARX

Watchlist Manager
Aroa Biosurgery Ltd Logo
Aroa Biosurgery Ltd
ASX:ARX
Watchlist
Price: 0.56 AUD 0.9%
Market Cap: AU$193.7m
Write Note Create Alert Ask AI

Wall St Price Targets

ARX Price Targets Summary
Aroa Biosurgery Ltd

Wall Street analysts forecast ARX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARX is 1.09 AUD with a low forecast of 0.8 AUD and a high forecast of 1.42 AUD.

ARX Lowest Forecast
Wall Street Target
AU$0.8
42% Upside
ARX Average Forecast
Wall Street Target
AU$1.09
95% Upside
ARX Highest Forecast
Wall Street Target
AU$1.42
153% Upside
Lowest Forecast
Price Target
0.8 AUD
42% Upside
Average Forecast
Price Target
1.09 AUD
95% Upside
Highest Forecast
Price Target
1.42 AUD
153% Upside
Aroa Biosurgery Ltd Competitors:
Price Targets

Revenue
Forecast

24% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
24% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 7 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 7 years is 13%.

What are analyst estimates?

Gross Profit
Forecast

27% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
27% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 7 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 3 years is 15%.

What are analyst estimates?

Operating Income
Forecast

32% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
18%
Average Beat
32% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
18%
Average Beat

Over the last 7 years, the compound annual growth rate for Operating Income has been 32%. The projected CAGR for the next 7 years is 32%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
75%
Average Beat
N/A
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
75%
Average Beat

The compound annual growth rate for Pre-Tax Income over the next 3 years is 54%.

What are analyst estimates?

Net Income
Forecast

25% / Year
Past Growth
51% / Year
Estimated Growth
Estimates Accuracy
56%
Average Beat
25% / Year
Past Growth
51% / Year
Estimated Growth
Estimates Accuracy
56%
Average Beat

Over the last 7 years, the compound annual growth rate for Net Income has been 25%. The projected CAGR for the next 3 years is 51%.

What are analyst estimates?

Continue ARX Research

Summary
ARX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ARX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ARX stock valuation using valuation multiples.
Wall St Estimates
ARX price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ARX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Aroa Biosurgery Ltd listings:
OTC • USD
AROAF
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ARX's stock price target?
Price Target
1.09 AUD

According to Wall Street analysts, the average 1-year price target for ARX is 1.09 AUD with a low forecast of 0.8 AUD and a high forecast of 1.42 AUD.

What is the Revenue forecast for Aroa Biosurgery Ltd?
Projected CAGR
13%

Over the last 7 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 7 years is 13%.

What is the Gross Profit forecast for Aroa Biosurgery Ltd?
Projected CAGR
15%

Over the last 7 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 3 years is 15%.

What is the Operating Income forecast for Aroa Biosurgery Ltd?
Projected CAGR
32%

Over the last 7 years, the compound annual growth rate for Operating Income has been 32%. The projected CAGR for the next 7 years is 32%.

What is the Pre-Tax Income forecast for Aroa Biosurgery Ltd?
Projected CAGR
54%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 54%.

What is the Net Income forecast for Aroa Biosurgery Ltd?
Projected CAGR
51%

Over the last 7 years, the compound annual growth rate for Net Income has been 25%. The projected CAGR for the next 3 years is 51%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.